Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Barkin

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 1998
Splenic abscess caused by Propionibacterium avidum as a complication of cardiac catheterizationA Vohra, E Saiz, J Chan, et al.
Pancreas|April 17, 1999
Workup of a patient with familial pancreatic cancerW M Steinberg, J Barkin, E L Bradley, et al.
AJR. American Journal of Roentgenology|November 1, 1983
The role of percutaneous aspiration in the diagnosis of pancreatic abscessM C Hill, J L Dach, J Barkin, et al.
Mineral and Electrolyte Metabolism|January 1, 1985
Bone mineral content in idiopathic calcium nephrolithiasisJ Barkin, D R Wilson, M A Manuel, et al.
JAMA|November 7, 1977
Computerized tomography, diagnostic ultrasound, and radionuclide scanning. Comparison of efficacy in diagnosis of pancreatic carcinomaJ Barkin, D Vining, A Miale, et al.
Disease-A-Month : DM|August 1, 1996
Management of chronic pain. Part IIR L Barkin, T R Lubenow, S Bruehl, et al.
Urology|August 30, 2000
Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trialJ C Nickel, B Johnston, J Downey, et al.
Disease-A-Month : DM|July 1, 1996
Management of chronic pain. Part IR L Barkin, T R Lubenow, S Bruehl, et al.
European Urology|September 23, 2003
Alpha-blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5alpha-reductase inhibitor dutasterideJ Barkin, M Guimarães, G Jacobi, et al.
Urology|April 10, 1999
CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Canadian Urologic Oncology GroupL H Klotz, S L Goldenberg, M Jewett, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 1998
Splenic abscess caused by Propionibacterium avidum as a complication of cardiac catheterizationA Vohra, E Saiz, J Chan, et al.
Pancreas|April 17, 1999
Workup of a patient with familial pancreatic cancerW M Steinberg, J Barkin, E L Bradley, et al.
AJR. American Journal of Roentgenology|November 1, 1983
The role of percutaneous aspiration in the diagnosis of pancreatic abscessM C Hill, J L Dach, J Barkin, et al.
Mineral and Electrolyte Metabolism|January 1, 1985
Bone mineral content in idiopathic calcium nephrolithiasisJ Barkin, D R Wilson, M A Manuel, et al.
JAMA|November 7, 1977
Computerized tomography, diagnostic ultrasound, and radionuclide scanning. Comparison of efficacy in diagnosis of pancreatic carcinomaJ Barkin, D Vining, A Miale, et al.
Disease-A-Month : DM|August 1, 1996
Management of chronic pain. Part IIR L Barkin, T R Lubenow, S Bruehl, et al.
Urology|August 30, 2000
Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trialJ C Nickel, B Johnston, J Downey, et al.
Disease-A-Month : DM|July 1, 1996
Management of chronic pain. Part IR L Barkin, T R Lubenow, S Bruehl, et al.
European Urology|September 23, 2003
Alpha-blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5alpha-reductase inhibitor dutasterideJ Barkin, M Guimarães, G Jacobi, et al.
Urology|April 10, 1999
CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results. Canadian Urologic Oncology GroupL H Klotz, S L Goldenberg, M Jewett, et al.
Pageof 5